{
    "Orphapacket": {
        "ORPHApacketId": "615938",
        "creationDate": "2023-06-19 09:22:44",
        "version": "1.3.25 / 4.1.7 [2023-04-17] (orientdb version)",
        "copyright": "Orphanet (c) 2023",
        "ORPHAcode": "615938",
        "Label": "Spastic paraparesis-cataracts-speech delay syndrome",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_615938",
        "DisorderType": {
            "value": "Clinical syndrome",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377792"
        },
        "Synonyms": [
            {
                "Synonym": "Fatty acyl-CoA reductase 1 superactivity"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "619338",
                "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "352306",
                        "Label": "Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with central nervous system predominant involvement"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "100979",
                        "Label": "Autosomal dominant complex spastic paraplegia"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "68385",
                        "Label": "Neurometabolic disease"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "98644",
                        "Label": "Metabolic disease with cataract"
                    }
                ]
            }
        ]
    }
}